Recent Finacing
Recent Raise
iOmx Therapeutics (Martinsried/Munich) uses its iOTarg high-throughput platform to identify tumor-associated immune checkpoints and advance preclinical antibody and kinase-targeting cancer programs IMT-07 and IMT-18.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
